Oestrogens and breast cancer: biological considerations
- PMID: 1933227
- DOI: 10.1093/oxfordjournals.bmb.a072485
Oestrogens and breast cancer: biological considerations
Abstract
The biology of oestrogens as applied to the development and progression of breast cancer has been reviewed. Particular consideration has been given to: (i) the sources by which the breast and its tumours may be supplied with oestrogen; (ii) the patterns of endogenous oestrogens within the breast; (iii) the mechanisms by which oestrogens may exert their action; and (iv) the molecular events which follow oestrogen deprivation and which may lead to hormone independence. From a greater understanding of these fundamental processes, novel antioestrogenic measures are being developed which represent more acceptable endocrine treatments for patients with breast cancer and offer the hope of preventative medicine for individuals at high risk of the disease.
Similar articles
-
Endocrine treatment for breast cancers: biological rationale and current progress.J Steroid Biochem Mol Biol. 1990 Nov 30;37(4):467-80. doi: 10.1016/0960-0760(90)90390-7. J Steroid Biochem Mol Biol. 1990. PMID: 2278830 Review.
-
Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer.Br J Cancer. 2002 Oct 21;87(9):950-5. doi: 10.1038/sj.bjc.6600587. Br J Cancer. 2002. PMID: 12434282 Free PMC article. Clinical Trial.
-
Aromatase inhibitors and breast cancer.Minerva Endocrinol. 2006 Mar;31(1):27-46. Minerva Endocrinol. 2006. PMID: 16498362 Review.
-
Novel approaches to the endocrine therapy of breast cancer.Eur J Cancer. 1990;26(9):989-92. doi: 10.1016/0277-5379(90)90628-7. Eur J Cancer. 1990. PMID: 1980589 Review. No abstract available.
-
Inhibitors of steroidogenic enzymes for the treatment of breast cancer.J Steroid Biochem Mol Biol. 1991 Nov;39(5B):805-9. doi: 10.1016/0960-0760(91)90029-5. J Steroid Biochem Mol Biol. 1991. PMID: 1954170 Review.
Cited by
-
Predicting health effects of exposures to compounds with estrogenic activity: methodological issues.Environ Health Perspect. 1997 Apr;105 Suppl 3(Suppl 3):655-63. doi: 10.1289/ehp.97105s3655. Environ Health Perspect. 1997. PMID: 9168010 Free PMC article. Review.
-
Evaluation of adverse effects in tamoxifen exposed healthy female dogs.Acta Vet Scand. 2010 Dec 22;52(1):67. doi: 10.1186/1751-0147-52-67. Acta Vet Scand. 2010. PMID: 21176231 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical